Finally, peroxisome and fatty acid degradation signal pathways, which may be the most likely KEGG pathways for EPHX2 to act as the core gene in the target gene sets in the inhibition of the progression of CRC, were labelled (Figure 7B). The gene discussed is EPHX2; the disease is colorectal carcinoma.